Chronic Hypoxia Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Knockout Mice-Reference-Cited by-同舟云学术

Chronic Hypoxia Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Knockout Mice

Published:2005 Issue:10 Volume:28 Page:837-845
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

NAKANO Daisuke,HAYASHI Tetsuya,TAZAWA Naoko,YAMASHITA Chika,INAMOTO Sakiko,OKUDA Nobuaki,MORI Tatsuhiko,SOHMIYA Koichi,KITAURA Yasushi,OKADA Yoshikatsu,MATSUMURA Yasuo

Publisher

Japanese Society of Hypertension

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference39 articles.

1. 1. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D: Probucol inhibits oxidative modification of low-density lipoprotein. J Clin Invest 1986; 77: 641-644.

2. p47phox is required for atherosclerotic lesion progression in ApoE–/– mice

3. 3. Williams RJ, Motteram JM, Sharp CH, Gallagher PJ: Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 1992; 94: 153-159.

4. 4. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J Clin Invest 1996; 98: 2572-2579.

5. Carvedilol Inhibits Pressure-Induced Increase in Oxidative Stress in Coronary Smooth Muscle Cells.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the role of myeloperoxidase in the atherosclerotic process in hypoxic mice based on the MAPK signaling pathway;Biochemical Pharmacology;2024-07

2. Molecular Pathways of Vulnerable Carotid Plaques at Risk of Ischemic Stroke: A Narrative Review;International Journal of Molecular Sciences;2024-04-15

3. Continuous Hypobaric Hypoxia may Promote Atherosclerosis Progression in Apolipoprotein E-deficient Mice;International Journal of Medical Sciences;2023

4. Intermittent Hypoxia and Atherosclerosis: From Molecular Mechanisms to the Therapeutic Treatment;Oxidative Medicine and Cellular Longevity;2022-08-03

5. Cholesterol and HIF-1α: Dangerous Liaisons in Atherosclerosis;Frontiers in Immunology;2022-03-21